The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission.

Condition:   Diffuse Large B-cell Lymphoma Interventions:   Drug: Mitoxantrone hydrochloride liposome injection;   Drug: RiTUXimab Injection;   Drug: Cyclophosphamid;   Drug: Vincristine;   Drug: Prednisolone Sponsors:   The First Hospital of Jilin University;   CSPC Ouyi Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials